0001104659-21-130026.txt : 20211026 0001104659-21-130026.hdr.sgml : 20211026 20211026170135 ACCESSION NUMBER: 0001104659-21-130026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211026 FILED AS OF DATE: 20211026 DATE AS OF CHANGE: 20211026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atlas Venture Fund XI, L.P. CENTRAL INDEX KEY: 0001708269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 211349389 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atlas Venture Opportunity Fund I, L.P. CENTRAL INDEX KEY: 0001759241 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 211349388 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE, 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE, 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 tm2130646-24_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-10-26 0 0001840233 Xilio Therapeutics, Inc. XLO 0001708269 Atlas Venture Fund XI, L.P. 300 TECHNOLOGY SQUARE, 8TH FLOOR CAMBRIDGE MA 02139 0 0 1 0 0001759241 Atlas Venture Opportunity Fund I, L.P. 400 TECHNOLOGY SQUARE, 10TH FLOOR CAMBRIDGE MA 02139 0 0 1 0 Common Stock 2021-10-26 4 C 0 1372998 A 1399313 I See Footnote Common Stock 2021-10-26 4 C 0 624089 A 2023402 I See Footnote Common Stock 2021-10-26 4 C 0 548442 A 548442 I See Footnote Common Stock 2021-10-26 4 P 0 187500 16.00 A 735942 I See Footnote Series A1 Preferred Stock 2021-10-26 4 C 0 13043477 D Common Stock 1372998 0 I See Footnote Series B Preferred Stock 2021-10-26 4 C 0 5928852 D Common Stock 624089 0 I See Footnote Series C Preferred Stock 2021-10-26 4 C 0 5210204 D Common Stock 548442 0 I See Footnote The Series A1 Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series A1 Preferred Stock had no expiration date. The shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI"). The general partner of Atlas Venture Fund XI is Atlas Venture Associates XI, L.P. ("AVA XI LP"). Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. Each of AVA XI LP and AVA XI LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund XI, except to the extent of its pecuniary interest therein, if any. The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date. The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date. The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any. Atlas Venture Fund XI, L.P. By: Atlas Venture Associates XI, L.P., Its: General Partner By: Atlas Venture Associates XI, LLC, Its General Partner, By: /s/ Ommer Chohan 2021-10-26 Atlas Venture Opportunity Fund I, L.P. By: Atlas Venture Associates Opportunity I, L.P., Its: General Partner By: Atlas Venture Associates Opportunity I, LLC, Its General Partner, By: /s/ Ommer Chohan 2021-10-26